» Articles » PMID: 38523684

Targeting Neutrophil Extracellular Traps in Gouty Arthritis: Insights into Pathogenesis and Therapeutic Potential

Overview
Journal J Inflamm Res
Publisher Dove Medical Press
Date 2024 Mar 25
PMID 38523684
Authors
Affiliations
Soon will be listed here.
Abstract

Gouty arthritis (GA) is an immune-mediated disorder characterized by severe inflammation due to the deposition of monosodium urate (MSU) crystals in the joints. The pathophysiological mechanisms of GA are not yet fully understood, and therefore, the identification of effective therapeutic targets is of paramount importance. Neutrophil extracellular traps (NETs), an intricate structure of DNA scaffold, encompassing myeloperoxidase, histones, and elastases - have gained significant attention as a prospective therapeutic target for gouty arthritis, due to their innate antimicrobial and immunomodulatory properties. Hence, exploring the therapeutic potential of NETs in gouty arthritis remains an enticing avenue for further investigation. During the process of gouty arthritis, the formation of NETs triggers the release of inflammatory cytokines, thereby contributing to the inflammatory response, while MSU crystals and cytokines are sequestered and degraded by the aggregation of NETs. Here, we provide a concise summary of the inflammatory processes underlying the initiation and resolution of gouty arthritis mediated by NETs. Furthermore, this review presents an overview of the current pharmacological approaches for treating gouty arthritis and summarizes the potential of natural and synthetic product-based inhibitors that target NET formation as novel therapeutic options, alongside elucidating the intrinsic challenges of these inhibitors in NETs research. Lastly, the limitations of HL-60 cell as a suitable substitute of neutrophils in NETs research are summarized and discussed. Series of recommendations are provided, strategically oriented towards guiding future investigations to effectively address these concerns. These findings will contribute to an enhanced comprehension of the interplay between NETs and GA, facilitating the proposition of innovative therapeutic strategies and novel approaches for the management of GA.

Citing Articles

Current Status of Gout Arthritis: Current Approaches to Gout Arthritis Treatment: Nanoparticles Delivery Systems Approach.

Herdiana Y, Wardhana Y, Kurniawansyah I, Gozali D, Wathoni N, Sofian F Pharmaceutics. 2025; 17(1).

PMID: 39861750 PMC: 11768112. DOI: 10.3390/pharmaceutics17010102.


Neutrophil Extracellular Trap Formation Model Induced by Monosodium Urate and Phorbol Myristate Acetate: Involvement in MAPK Signaling Pathways.

Wu C, Xu X, Shi Y, Li F, Zhang X, Huang Y Int J Mol Sci. 2025; 26(1.

PMID: 39796001 PMC: 11719704. DOI: 10.3390/ijms26010143.


Gouty arthritis patients' diagnostic, biochemical, and hematological characteristics study: a single-center retrospective study.

Li H, Liu J, Shao Z, Xiong W, Cheng L BMC Musculoskelet Disord. 2024; 25(1):1054.

PMID: 39707267 PMC: 11660823. DOI: 10.1186/s12891-024-08151-0.


Phillyrin inhibits oxidative stress and neutrophil extracellular trap formation through the KEAP1/NRF2 pathway in gouty arthritis.

Xu X, Lu Y, Shen R, Fang L Immunol Res. 2024; 72(6):1489-1501.

PMID: 39436625 DOI: 10.1007/s12026-024-09548-8.


Mechanism of Reactive Oxygen Species-Guided Immune Responses in Gouty Arthritis and Potential Therapeutic Targets.

Zhang S, Li D, Fan M, Yuan J, Xie C, Yuan H Biomolecules. 2024; 14(8).

PMID: 39199366 PMC: 11353092. DOI: 10.3390/biom14080978.


References
1.
Szatmary P, Huang W, Criddle D, Tepikin A, Sutton R . Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders. J Cell Mol Med. 2018; 22(10):4617-4629. PMC: 6156248. DOI: 10.1111/jcmm.13797. View

2.
Song M, Wang J, Sun Y, Pang J, Li X, Liu Y . Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis. Acta Pharm Sin B. 2022; 12(3):1213-1224. PMC: 9069405. DOI: 10.1016/j.apsb.2021.10.006. View

3.
Orhan I, Deniz F . Natural Products and Extracts as Xantine Oxidase Inhibitors - A Hope for Gout Disease?. Curr Pharm Des. 2020; 27(2):143-158. DOI: 10.2174/1381612826666200728144605. View

4.
Euler M, Hoffmann M . The double-edged role of neutrophil extracellular traps in inflammation. Biochem Soc Trans. 2019; 47(6):1921-1930. DOI: 10.1042/BST20190629. View

5.
Riley J, Tait S . Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020; 21(4):e49799. PMC: 7132203. DOI: 10.15252/embr.201949799. View